Friday, Aug. 28, 2015, 72 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $47.90 to $8,027,410.00.

Highlighted Stocks Traded by Insiders:

PennantPark Floating Rate Capital (PFLT) - FREE Research Report

Katz Samuel L, who is Director at PennantPark Floating Rate Capital, bought 7,482 shares at $12.00 on Aug. 28, 2015. Following this transaction, the Director owned 79,500 shares meaning that the stake was boosted by 10.39% with the 7,482-share transaction.

The shares most recently traded at $12.07, up $0.07, or 0.58% since the insider transaction. Historical insider transactions for PennantPark Floating Rate Capital go as follows:

  • 4-Week # shares bought: 27,518
  • 12-Week # shares bought: 27,518
  • 24-Week # shares bought: 27,518

The average volume for PennantPark Floating Rate Capital has been 81,800 shares per day over the past 30 days. PennantPark Floating Rate Capital has a market cap of $182.9 million and is part of the financial sector and financial services industry. Shares are down 11.58% year-to-date as of the close of trading on Friday.

PennantPark Floating Rate Capital Ltd. is a business development company. It seeks to make secondary direct, debt, equity, and loan investments. The fund seeks to invest through floating rate loans in private or thinly traded or small market-cap, public middle market companies. The stock currently has a dividend yield of 9.28%. The company has a P/E ratio of 8.9. Currently, there is 1 analyst who rates PennantPark Floating Rate Capital a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on PFLT - FREE

TheStreet Quant Ratings

rates PennantPark Floating Rate Capital as a

hold

. Among the primary strengths of the company is its expanding profit margins over time. At the same time, however, we also find weaknesses including disappointing return on equity, weak operating cash flow and a generally disappointing performance in the stock itself. Get the full

PennantPark Floating Rate Capital Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Cell Therapeutics (CTIC) - FREE Research Report

Singer Jack W, who is EVP, Global Medical Affairs at Cell Therapeutics, sold 15,000 shares at $1.58 on Aug. 28, 2015. Following this transaction, the EVP, Global Medical Affairs owned 1.3 million shares meaning that the stake was reduced by 1.18% with the 15,000-share transaction.

The shares most recently traded at $3.01, up $1.43, or 47.47% since the insider transaction. Historical insider transactions for Cell Therapeutics go as follows:

  • 4-Week # shares sold: 10,000
  • 12-Week # shares sold: 70,000
  • 24-Week # shares sold: 521,498

The average volume for Cell Therapeutics has been 3.7 million shares per day over the past 30 days. Cell Therapeutics has a market cap of $440.5 million and is part of the health care sector and drugs industry. Shares are up 53.93% year-to-date as of the close of trading on Tuesday.

CTI BioPharma Corp., a biopharmaceutical company, engages in the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States and internationally.

Exclusive Offer: Get the latest Stock Analysis on CTIC - FREE

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

NuStar GP Holdings (NSH) - FREE Research Report

Greehey William E, who is Director at NuStar GP Holdings, bought 57,503 shares at $32.87 on Aug. 28, 2015. Following this transaction, the Director owned 8.5 million shares meaning that the stake was boosted by 0.68% with the 57,503-share transaction.

The shares most recently traded at $32.65, down $0.22, or 0.68% since the insider transaction. Historical insider transactions for NuStar GP Holdings go as follows:

  • 4-Week # shares bought: 151,045
  • 12-Week # shares bought: 186,500
  • 24-Week # shares bought: 216,500

The average volume for NuStar GP Holdings has been 142,200 shares per day over the past 30 days. NuStar GP Holdings has a market cap of $1.4 billion and is part of the basic materials sector and energy industry. Shares are down 2.47% year-to-date as of the close of trading on Friday.

NuStar GP Holdings, LLC, through its ownership interests in NuStar Energy L.P., engages in the transportation of petroleum products and anhydrous ammonia; terminalling and storage of petroleum products; and marketing of petroleum products. The stock currently has a dividend yield of 6.46%. The company has a P/E ratio of 19.4. Currently, there are 3 analysts who rate NuStar GP Holdings a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on NSH - FREE

TheStreet Quant Ratings

rates NuStar GP Holdings as a

hold

. The company's strengths can be seen in multiple areas, such as its notable return on equity, good cash flow from operations and expanding profit margins. However, as a counter to these strengths, we find that the stock has had a generally disappointing performance in the past year. Get the full

NuStar GP Holdings Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.